Levent Tabak
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Sarcoidosis and Beryllium Toxicity Research 5
- Lysosomal Storage Disorders Research 1
-
- Blood Coagulation and Thrombosis Mechanisms 3
- Co-authors
- Zeki Kılıçaslan (4 shared papers)Mustafa Erelel (2 shared papers)Çağlar Çuhadaroğlu (1 shared paper)Helmut Teschler (1 shared paper)Feyza Erkan (2 shared papers)Gerhard Hoheisel (1 shared paper)Ulrich Costabel (1 shared paper)Dilek Yılmazbayhan (3 shared papers)
In The Last Decade
Levent Tabak
21 papers receiving 327 citations
Peers
Comparison fields: 5 of 44
- Infectious Diseases 112
- Internal Medicine 18
- Physiology 130
- Hematology 22
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Levent Tabak
This map shows the geographic impact of Levent Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Tabak more than expected).
Fields of papers citing papers by Levent Tabak
This network shows the impact of papers produced by Levent Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Tabak. The network helps show where Levent Tabak may publish in the future.
Co-authors
The 25 scholars most cited alongside Levent Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 56 | |
| 2 | 2002 | 50 | |
| 3 | 2009 | 49 | |
| 4 | 2020 | 41 | |
| 5 | 2021 | 31 | |
| 6 | 2010 | 26 | |
| 7 | 2007 | 23 | |
| 8 | 1994 | 17 | |
| 9 | 2002 | 15 | |
| 10 | The value of labial biopsy in the differentiation of sarcoidosis from tuberculosis. | 2001 | 9 |
| 11 | 2014 | 6 | |
| 12 | 2016 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2007 | 5 | |
| 15 | 2005 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2019 | 3 | |
| 18 | INHERITED THROMBOPHILIC RISK FACTORS IN VENOUSTHROMBOEMBOLISM: FACTOR V LEIDEN AND PROTHROMBIN 20210 A | 2004 | 2 |
| 19 | Karaciğer Sirozunda Hipoksemi | 1992 | 1 |
| 20 | Comparison of three clinical scoring methods in patients with pulmonary thromboembolism. | 2009 | 1 |
About Levent Tabak
Levent Tabak is a scholar working on Physiology, Hematology, Pulmonary and Respiratory Medicine, Toxicology and Infectious Diseases, having authored 23 papers that have together received 356 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Tuberculosis Research and Epidemiology (2 papers), Lysosomal Storage Disorders Research (1 paper), COVID-19 Clinical Research Studies (1 paper) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Infectious Diseases (112 citations), Internal Medicine (18 citations), Physiology (130 citations), Hematology (22 citations) and Pulmonary and Respiratory Medicine (45 citations). Levent Tabak has collaborated with scholars based in Türkiye, Germany and Sweden. Frequent co-authors include Zeki Kılıçaslan, Mustafa Erelel, Çağlar Çuhadaroğlu, Helmut Teschler, Feyza Erkan, Gerhard Hoheisel, Ulrich Costabel, Dilek Yılmazbayhan, Esen Kıyan and Mahir Kapmaz. Their work appears in journals such as Respiratory Medicine, European Respiratory Journal, Respirology, International Journal of Infectious Diseases and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.